242 related articles for article (PubMed ID: 31108181)
1. Breakthrough reactions during rapid drug desensitization: Clinical outcome and risk factors.
Kang Y; Kwon OY; Jung H; Kang M; An J; Lee JH; Won HK; Song WJ; Kwon HS; Cho YS; Moon HB; Kim TB
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):48-56.e1. PubMed ID: 31108181
[TBL] [Abstract][Full Text] [Related]
2. Platin desensitizations in thoracic malignancies and risk factors for breakthrough reactions.
Buhari GK; Kalkan İK; Ateş H; Bahçecioğlu SN; Demir Ş; Yeşilkaya S; Solak GTV; Aksu K; Erkekol FÖ
Allergol Immunopathol (Madr); 2023; 51(2):130-136. PubMed ID: 36916098
[TBL] [Abstract][Full Text] [Related]
3. Rapid desensitization to antineoplastic drugs in an outpatient immunoallergology clinic: Outcomes and risk factors.
Caiado J; Brás R; Paulino M; Costa L; Castells M
Ann Allergy Asthma Immunol; 2020 Sep; 125(3):325-333.e1. PubMed ID: 32353405
[TBL] [Abstract][Full Text] [Related]
4. A new non-dilution rapid desensitization protocol successfully applied to all-grade platinum hypersensitivity.
Chung SJ; Kang SY; Kang RY; Kim YC; Lee KH; Kim TY; Han SW; Kang HR
Cancer Chemother Pharmacol; 2018 Nov; 82(5):777-785. PubMed ID: 30105458
[TBL] [Abstract][Full Text] [Related]
5. Rapid drug desensitization with platin-based chemotherapy: Analysis of risk factors for breakthrough reactions.
Gorgulu Akin B; Erkoc M; Korkmaz ET; Ozdel Ozturk B; Colak S; Ozalp Ates FS; Bavbek S
World Allergy Organ J; 2022 Jan; 15(1):100619. PubMed ID: 34992710
[TBL] [Abstract][Full Text] [Related]
6. Outpatient rapid 4-step desensitization for gynecologic oncology patients with mild to low-risk, moderate hypersensitivity reactions to carboplatin/cisplatin.
Li Q; Cohn D; Waller A; Backes F; Copeland L; Fowler J; Salani R; O'Malley D
Gynecol Oncol; 2014 Oct; 135(1):90-4. PubMed ID: 25110329
[TBL] [Abstract][Full Text] [Related]
7. Rapid Drug Desensitization with Chemotherapeutics (Platins, Taxanes, and Others): A Single-Center Retrospective Study.
Kendirlinan R; Gümüşburun R; Çerçi P; Özbek E; Altıner S; Çelebi Sözener Z; Soyyiğit Ş; Aydın Ö; Bavbek S
Int Arch Allergy Immunol; 2019; 179(2):114-122. PubMed ID: 30893688
[TBL] [Abstract][Full Text] [Related]
8. One-Dilution Rapid Desensitization Protocol to Chemotherapeutic and Biological Agents: A Five-Year Experience.
Sala-Cunill A; Molina-Molina GJ; Verdesoto JT; Labrador-Horrillo M; Luengo O; Galvan-Blasco P; Guilarte M; Cardona V
J Allergy Clin Immunol Pract; 2021 Nov; 9(11):4045-4054. PubMed ID: 34214705
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Breakthrough Reactions in 1,143 Desensitization Procedures in a Single Tertiary Hospital Using a One-Bag Desensitization Protocol.
Kim HH; Seo J; Ahn YH; Kim H; Yoon JE; Suh JH; Kang DY; Lee SY; Kang HR
Front Allergy; 2022; 3():786822. PubMed ID: 35386661
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of rapid drug desensitization in children.
Esenboga S; Akarsu A; Ocak M; Gur Cetinkaya P; Sahiner UM; Sekerel BE; Soyer O
Pediatr Allergy Immunol; 2022 Mar; 33(3):e13759. PubMed ID: 35338724
[TBL] [Abstract][Full Text] [Related]
11. Rapid Drug Desensitization with Biologics: A Single-Center Experience with Four Biologics.
Bavbek S; Kendirlinan R; Çerçi P; Altıner S; Soyyiğit Ş; Çelebi Sözener Z; Aydın Ö; Gümüşburun R
Int Arch Allergy Immunol; 2016; 171(3-4):227-233. PubMed ID: 28049204
[TBL] [Abstract][Full Text] [Related]
12. Outpatient desensitization of patients with moderate (high-risk) to severe platinum hypersensitivity reactions.
Vetter MH; Khan A; Backes FJ; Bixel K; Cohn DE; Copeland LJ; Fowler JM; Salani R; Li Q; O'Malley DM
Gynecol Oncol; 2019 Feb; 152(2):316-321. PubMed ID: 30503265
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
[TBL] [Abstract][Full Text] [Related]
14. Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
Otani IM; Wong J; Banerji A
Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity.
Limsuwan T; Castells MC
Expert Opin Drug Saf; 2010 Jan; 9(1):39-53. PubMed ID: 20001753
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of a Undiluted, One-Bag Desensitization Protocol for Chemotherapeutic Agents.
Iglesias-Santamaría A; Castellano Copa P
Ann Pharmacother; 2023 Jan; 57(1):55-61. PubMed ID: 35570798
[TBL] [Abstract][Full Text] [Related]
17. Platinum desensitization in patients with carboplatin hypersensitivity: A single-institution retrospective study.
Altwerger G; Gressel GM; English DP; Nelson WK; Carusillo N; Silasi DA; Azodi M; Santin A; Schwartz PE; Ratner ES
Gynecol Oncol; 2017 Jan; 144(1):77-82. PubMed ID: 27789084
[TBL] [Abstract][Full Text] [Related]
18. Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.
Giavina-Bianchi P; Galvão VR; Picard M; Caiado J; Castells MC
J Allergy Clin Immunol Pract; 2017; 5(3):728-736. PubMed ID: 28034549
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
[TBL] [Abstract][Full Text] [Related]
20. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment.
Madrigal-Burgaleta R; Berges-Gimeno MP; Angel-Pereira D; Ferreiro-Monteagudo R; Guillen-Ponce C; Pueyo C; Gomez de Salazar E; Alvarez-Cuesta E
Allergy; 2013 Jul; 68(7):853-61. PubMed ID: 23647576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
